Sprites
Mein FinanzNachrichtenJetzt AnmeldenPasswort vergessen?
Montag, 28.05.2012Börsentäglich über 11.000 News von 416 internationalen Medien
Erweiterte
Suche
Ad hoc-Mitteilungen

CAMBRIDGE HEART INC

WKN: 902220  ISIN: US1319101010  Ticker-Symbol: CR7 
Aktie:
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
CAMBRIDGE HEART INC Chart 1 Jahr
1-Woche-Intraday-Chart
CAMBRIDGE HEART INC 1-Woche-Intraday-Chart

Aktuelle News zur CAMBRIDGE HEART Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
15.05. 39
Cambridge Heart, Inc. (OTCBB: CAMH), a developer of non-invasive diagnostic tests for cardiac disease, today reported results for its first quarter ended March...
Mehr lesen zu:
Cambridge Heart Reports Results for the Three Months Ended March 31, 2012
30.03. -
30.03. 35
Cambridge Heart, Inc. (OTCBB: CAMH), a developer of non-invasive diagnostic tests for cardiac disease, today reported results for its fourth quarter and full year...
Mehr lesen zu:
Cambridge Heart Reports Results for the Three and Twelve Months Ended December 31, 2011
19.03. 35
New Study Published in Heart Rhythm Journal Shows Patients with Positive Test Result Are Nearly Nine Times More Likely To Experience Sudden Cardiac Arrest Cambridge...
Mehr lesen zu:
New Study Finds Cambridge Heart's MTWA Test to Be a Powerful Predictor of Sudden Cardiac Arrest
16.03. 34
Decision Allows for Broader Adoption of MTWA in Japan Cambridge Heart, Inc. (OTCBB: CAMH), a developer of non-invasive diagnostic tests for...
Mehr lesen zu:
Cambridge Heart Announces Microvolt T-Wave Alternans Receives Reimbursement Coverage in Japan
18.01. 26
Cambridge Heart, Inc. (OTCBB: CAMH), a developer of non-invasive diagnostic tests for cardiac disease, today announced that on January 17, 2012 it completed an initial...
Mehr lesen zu:
Cambridge Heart Completes First Close in Private Placement
05.01. 30
Company reports a significant increase in MTWA Module orders Cambridge Heart, Inc. (OTCBB: CAMH), a developer of non-invasive diagnostic tests...
Mehr lesen zu:
Cambridge Heart Announces Preliminary Fourth Quarter Revenue and Module Results
7 Nachrichten in den letzten 6 Monaten